Diane B. Loseth

Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study

R. Portenoy, A. Lyss, R. Payne, 1999, PAIN.

Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms

K. Foley, R. Portenoy, G. Wong, 1994 .

Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms

K. Foley, R. Portenoy, G. Wong, 1994, Cancer.

Quality of life of women with ovarian cancer.

H. Thaler, R. Portenoy, G. Wong, 1995, Gynecologic oncology.

Psychiatric illness in the next of kin of patients who die in the intensive care unit*

H. Prigerson, M. Siegel, L. Vanderwerker, 2008, Critical care medicine.

Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain.

L. Hart, M. Simmonds, R. Portenoy, 2001, Journal of pain and symptom management.

Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study

R. Portenoy, A. Lyss, R. Payne, 1999, PAIN.

Management of opioid-induced sedation in patients with cancer.

M. Funk, D. B. Loseth, L. Bourdeanu, 2005, Clinical journal of oncology nursing.